Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS

v3.7.0.1
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2017
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 11 – SUBSEQUENT EVENTS

 

On July 31, 2017, we completed a share exchange agreement whereby we acquired 100% of the capital stock of Lewis & Clark Pharmaceuticals, Inc. in exchange for 7,122,172 shares of our common stock (50% of our issued and outstanding common stock, including common shares issuable upon conversion of all of our preferred stock). Certain of the common shares we issued to the shareholders of Lewis & Clark are escrowed, subject to certain indemnification provisions.